26 Oct 2007 Novel Alternative Approach to Inhibiting Insulin Growth Factor (IGF) May Provide New Treatment for Breast Cancer and Other Cancers
26 Oct 2007 Arius announces new findings in Trop-2 and CD59 CANCER antibody programs
25 Oct 2007 Human Genome Sciences presents new data showing anti-tumor activity and safety of trail receptor antibodies in combination with chemotherapy
25 Oct 2007 Milatuzumab Showed Promising Therapeutic Effects Alone and Combined With CD20 Antibody in Preclinical Studies
25 Oct 2007 ImmunoGen, Inc. Reports New Clinical and Preclinical Data at AACR-NCI-EORTC
25 Oct 2007 Seattle Genetics Reports Preclinical Data on SGN-40 and an Anti-CD19 Antibody-Drug Conjugate
25 Oct 2007 CuraGen Announces Presentation of Phase I Dose-Escalation Results on CR011- vcMMAE for Metastatic Melanoma
24 Oct 2007 ARIUS announces cancer stem cell antibody program successfully completes first toxicology study
24 Oct 2007 Micromet is Presenting Four Posters on BiTE(R) Antibodies at the International AACR-NCI-EORTC Conference
24 Oct 2007 GlaxoSmithKline And Tolerx Form Worldwide Collaboration For Development And Commercialization Of Novel Medication
24 Oct 2007 Phase I results announced for R1507 from Genmab's Collaboration with Roche
20 Oct 2007 BioWa Announces Licensing of POTELLIGENT(R) Technology by GlaxoSmithKline (GSK)
19 Oct 2007 Micromet Receives Regulatory Approval to Conduct a Phase 2 Clinical Trial Investigating MT103 (MEDI-538) in Patients with Acute Lymphoblastic Leukemia
19 Oct 2007 Lilly and MacroGenics Announce Licensing and Collaboration Agreement
19 Oct 2007 Abbott Scientists Create One Molecule With Two Antibody Functions
18 Oct 2007 Merck Serono Announces Joint Agreement with ImClone and Bristol-Myers Squibb for Erbitux in Japan
18 Oct 2007 ImmunoGen, Inc. Earns Milestone with Start of SAR3419 Clinical Testing
17 Oct 2007 Scientists Show Monoclonal Antibody Leads to Repair of Myelin Sheath in Laboratory Study of Multiple Sclerosis
16 Oct 2007 Bradmer provides Phase III Neuradiab trial update and guidance
16 Oct 2007 Top-Line Efficacy Data Presented from Phase 2 Trial of Alemtuzumab in Multiple Sclerosis
16 Oct 2007 Medimmune and Crucell announce collaboration to develop new antibodies for the treatment and prevention of hospital-acquired bacterial infection
13 Oct 2007 WILEX' second product enters Phase III trial: IND approval from FDA for registration trial with CA9-SCAN
12 Oct 2007 Genmab Amends HuMax-CD4 Pivotal Study in CTCL
12 Oct 2007 Phase 2 Data Show Daclizumab Significantly Reduced Multiple Sclerosis Lesions in Patients Receiving Interferon Beta Therapy
09 Oct 2007 MorphoSys Enters Therapeutic Research Collaboration on Novel Target Molecule with Genesis Research

La Merie Biologics

FREE Weekly News Bulletin

Sign Up

2018 Sales ofAntibodies & Proteins

New Product Alert

For La Merie Publishing

Sign Up